Successful management of a neurology infusion practice.
The increasing use of infusible biologic therapies, including the novel monoclonal antibody natalizumab for the treatment of relapsing forms of multiple sclerosis, has elicited much interest among neurologists in the provision of in-office infusions for their patients. An in-office infusion center may offer neurologists a means to provide integrated care for their patients in a familiar and supportive environment. This setting is especially convenient for chronically ill patients, allowing them to receive high-quality care under the direct supervision of their neurologist and facility staff. By administering infusible treatments in a neurology practice rather than referring patients to a hospital or oncology/hematology-based infusion center, the primary neurologist can more closely monitor clinical outcomes, treatment adherence, and the occurrence of adverse effects. In addition, there is greater opportunity for patient interaction and education, which can strengthen relationships with clinical caregivers. This model is also applicable to multispecialty or hospital-based neurology groups desiring to integrate neurology infusion services. In this article, we discuss overall management strategies; staffing and scheduling issues; general coding, billing, and reimbursement methodologies; and additional financial considerations.
Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT, USA (JFF); and Grassi & Co, Healthcare Niche, Jericho, NY, USA (AMD).
John F
JF
Foley
Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT, USA (JFF); and Grassi & Co, Healthcare Niche, Jericho, NY, USA (AMD).
Anne M
AM
Dunne